Congenital respiratory-biliary fistula, also called congenital tracheobiliary fistula or congenital bronchobiliary fistula, is a very rare birth defect. In this condition, an abnormal tube connects part of the airway to the biliary system, so bile can enter the breathing passages. This can cause choking, cough, green or yellow sputum, repeated chest infection, breathing trouble, and lung inflammation. Published reviews and case reports show that the most reliable curative treatment is surgical removal or repair of the fistula after careful imaging and bronchoscopy. Medicines help control infection, inflammation, pain, vomiting, reflux, and nutrition problems, but they do not usually close the fistula by themselves. PubMed PMC PMC
Congenital respiratory-biliary fistula is a very rare birth defect. It means there is an abnormal tube-like passage between part of the breathing system, such as the trachea or a bronchus, and part of the bile system, usually the left hepatic duct or another bile passage inside the liver. Because of this wrong connection, bile can move toward the airway, and air can sometimes move into the bile ducts. This can cause choking, breathing trouble, repeated lung infection, and green or yellow-green fluid in the mouth, sputum, or breathing tube. In medical papers, this disease is also described as a rare developmental anomaly of the foregut. [1][2][3]
Congenital respiratory-biliary fistula is also called congenital bronchobiliary fistula, congenital tracheobiliary fistula, congenital tracheo-biliary fistula, congenital broncho-biliary fistula, or congenital respiratory tract-biliary fistula. The exact name often depends on where the abnormal opening starts. If it starts from the trachea, doctors may call it tracheobiliary fistula. If it starts from a bronchus, they may call it bronchobiliary fistula. [1][4][5]
Types
- Tracheobiliary fistula: the abnormal tract starts from the trachea and goes to the biliary system. This type may cause very early breathing problems in a newborn because the opening is high in the airway. [4][6]
- Bronchobiliary fistula: the abnormal tract starts from a main bronchus and joins the bile ducts. This is one of the most often reported forms in case reviews. [2][6]
- Carinal type: the opening is near the tracheal carina, where the trachea divides into the two main bronchi. Reviews of reported cases show that this is also a common site. [3]
- Right bronchial type: the fistula opens into the right main bronchus. Several reports describe this as a frequent location. [3]
- Left bronchial type: the fistula opens into the left main bronchus. This seems less common than the right-sided form. [3]
This disease begins before birth, during early body development. In a healthy baby, the primitive foregut separates and forms different tubes for breathing and digestion, and the bile ducts form their own normal path. In congenital respiratory-biliary fistula, that normal separation and formation do not happen perfectly. A persistent abnormal passage remains between the airway and the biliary tree. Many patients become sick in the newborn period, but some are diagnosed later in infancy, childhood, or even adulthood if the fistula is small or symptoms are not typical. [1][2][4][6]
The condition is dangerous mainly because bile does not belong in the airway. Bile can irritate the trachea, bronchi, and lungs. This irritation can cause coughing, aspiration, pneumonia, low oxygen, and repeated chest illness. Some babies also have problems in the biliary tract itself, such as biliary atresia or a small common hepatic duct, which can make the illness more serious. Earlier symptoms often mean a larger fistula or a more severe associated malformation. [2][3][6]
Causes or developmental factors
The exact cause is not fully proven. Because this disease is very rare, doctors usually talk about proposed embryologic causes and reported developmental associations rather than 20 fully confirmed causes. The list below follows that careful meaning. [1][2][6]
- Abnormal foregut development is the main proposed cause. The primitive foregut does not develop in the usual way. [2]
- Failure of normal separation between the early airway and upper digestive tract may leave an abnormal connection behind. [2][6]
- Persistence of an embryonic tract can create a tube that should have disappeared before birth. [6]
- Abnormal budding from the tracheobronchial tree may produce a misplaced branch that joins the bile ducts. [6][7]
- Abnormal connection to the left hepatic duct is often described in rare-disease summaries and case reports. [1][5]
- A developmental error near the carina may explain cases where the fistula opens at the tracheal split. [3]
- A developmental error near the right main bronchus may explain many right-sided cases. [3]
- A developmental error near the left main bronchus may explain the smaller group of left-sided cases. [3]
- Biliary tract malformation can be part of the same developmental problem. Reports describe congenital respiratory-biliary fistula together with biliary abnormalities. [2][6]
- Biliary atresia is a reported associated congenital abnormality and may reflect shared abnormal development. [2][8]
- Hypoplastic common hepatic duct has been reported with congenital tracheobiliary fistula, suggesting linked bile-duct development problems. [9]
- Abnormal intrahepatic bile-duct formation may help create an unusual pathway for the fistula. [2][3]
- A tract passing through the diaphragmatic or esophageal hiatus suggests abnormal development of the route between chest and upper abdomen. [2][3]
- A congenital tube lined by respiratory-type tissue supports the idea of misplaced airway tissue during development. [3]
- Cartilage within the fistula wall suggests that part of the tract formed like airway tissue instead of normal bile duct tissue. [3]
- Muscle and submucosal glands in the tract also support a malformed airway-origin tube. [3]
- Genetic mutation or pathogenic variant is listed by GARD as a cause category for this rare disease, although specific genes are not well established in the usual case reports. [1]
- A sporadic developmental error during cell division is possible in some patients, especially when there is no family history. GARD notes that pathogenic changes may arise randomly. [1]
- Associated major congenital anomalies, such as hypoplastic left heart syndrome in a reported case, suggest that some patients may have broader early developmental disturbance. [9]
- Shared abnormal development of the respiratory tract and biliary system is the broad final explanation used across reviews, because the disease links two organs that arise and separate during early embryonic life. [2][6]
Symptoms
- Respiratory distress is one of the most important symptoms. A baby may breathe fast, work hard to breathe, or need oxygen. [1][2][7]
- Recurrent pneumonia is common because bile and infected secretions can enter the lungs again and again. [1][3][7]
- Choking during feeding or with secretions is often reported in newborn cases. [2]
- Bilious saliva means green or yellow-green saliva in the mouth. This is a very important clue in neonates. [2]
- Bile-like sputum or biliary expectoration means green sputum coughed up from the airway. Reviews describe this as a classic sign. [1][2]
- Bilious fluid from an endotracheal tube can be seen in very sick newborns who are intubated. [2][9]
- Cyanosis means a blue color of the lips or skin caused by low oxygen. It has been reported in neonatal and infant cases. [2][7]
- Apnea means pauses in breathing. Some newborns present this way very early in life. [2]
- Persistent cough can happen in older infants or children, especially when the fistula is small and diagnosis is delayed. [3][10]
- Vomiting, including bilious vomit in some cases, may occur because bile is moving abnormally and the airway-digestive system is irritated. [1][11]
- Jaundice can appear when there is associated bile-duct disease or bile-flow abnormality. [2]
- Poor feeding may happen because the baby coughs, chokes, or becomes breathless during feeding. [2][6]
- Poor weight gain or malnutrition can happen in children with long-standing respiratory symptoms and repeated illness. [12]
- Wheeze or noisy breathing may occur from airway irritation and repeated inflammation, although it is less specific than green sputum. [3][7]
- Poor response to usual antibiotic treatment can happen because the real problem is the abnormal fistula, not only infection. [3][7]
Diagnostic tests
These tests are grouped as you asked. Some tests help strongly confirm the fistula, while others help doctors judge severity, look for associated defects, or rule out other diseases. [2][3][7]
Physical exam tests:
- General respiratory examination checks breathing rate, chest retractions, nasal flaring, and work of breathing. This helps doctors see how severe the airway problem is. [1][2]
- Inspection of oral and airway secretions looks for green or yellow-green saliva, sputum, or tube secretions. This is a major bedside clue. [2][9]
- Lung auscultation with a stethoscope checks for crackles, reduced air entry, or noisy breathing caused by pneumonia or aspiration. [2][3]
- Examination for cyanosis checks whether the lips, tongue, or skin are turning blue from low oxygen. [2][7]
Manual or bedside procedural tests:
- Flexible bronchoscopy is one of the most important tests. It can directly show the abnormal opening in the trachea, carina, or bronchus and may show yellow-green bile coming out. [2][3][12]
- Catheter cannulation of the opening during bronchoscopy helps doctors enter the tract and define its path more clearly. [10]
- Bronchography or fistulography through the bronchoscope uses contrast dye to outline the whole tract and show where it reaches the bile ducts. This is a very useful confirmatory test. [2][3][10]
- Endobronchial blocker-assisted fistulography is a more specialized method. It can block reflux of contrast and improve visualization of the fistula and the biliary tree. [3]
Lab and pathological tests:
- Liver function tests, especially bilirubin, help check whether there is associated biliary obstruction or liver involvement. [2]
- Bronchoalveolar or tracheal lavage bile acid testing can show bile in airway fluid. A positive bile acid result strongly supports the diagnosis. [3][13]
- Infection blood tests, such as complete blood count and inflammatory markers, do not prove the fistula but help assess pneumonia and systemic illness. [2][3]
- Pathological examination of the removed fistula can confirm a congenital tract. Reported specimens may show cartilage, muscle, squamous lining, ciliated columnar lining, and glands. [3]
Electrodiagnostic or physiologic tests:
- Pulse oximetry measures oxygen level continuously and helps show the severity of respiratory compromise. It does not prove the fistula alone, but it is very useful in sick newborns and infants. [2][7]
- Electrocardiography can be used when a baby is critically ill or when doctors suspect associated congenital heart disease. It is supportive, not specific. [9]
- Cardiorespiratory monitoring helps detect apnea, unstable breathing, and low oxygen episodes in newborn cases. This is again supportive rather than confirmatory. [2][6]
Imaging tests:
- Chest X-ray may show pneumonia, chronic inflammatory change, or other lung shadowing, but it usually does not show the full fistula tract by itself. [3][7]
- Chest CT, especially 3D CT reconstruction, can show the abnormal tract and related lung disease. It is one of the key imaging tests in many reports. [2][3]
- Ultrasound of the liver and biliary tree may show air in the bile ducts, gallbladder, or common hepatic duct, and the bubbles may move with breathing. [2][3]
- Cholangiography, including intraoperative cholangiography, helps show bile-duct anatomy and looks for associated malformations before or during surgery. [2][11]
- MRCP or contrast-enhanced magnetic resonance cholangiography can show the biliary anatomy and the bile flow path. In some cases, MRI has clearly depicted the anomaly. [3][11][14]
- Hepatobiliary scintigraphy, often called a HIDA scan, can confirm abnormal communication and can also help after surgery. It has been used in classic reports. [10][11]
- Upper gastrointestinal contrast study may be done to rule out tracheoesophageal fistula or other swallowing-related problems when the diagnosis is unclear. [3]
Non-pharmacological treatments
1. Airway stabilization. The first non-drug treatment is keeping the airway open and the child breathing safely. This may include careful suctioning, oxygen, and positioning in a neonatal or pediatric intensive care unit. Its purpose is to lower immediate breathing danger. The mechanism is simple: less bile and secretion stay in the airway, so gas exchange improves and the lungs work better. PubMed PMC
2. Oxygen therapy. Oxygen is often needed when lung inflammation or pneumonia lowers blood oxygen. The purpose is to prevent low-oxygen injury to the brain and body. It works by increasing the oxygen concentration the patient breathes, which raises blood oxygen while the team prepares for definitive treatment. PubMed NCBI
3. Assisted ventilation when needed. Some babies or children need CPAP or mechanical ventilation if respiratory failure develops. The purpose is lifesaving breathing support. The mechanism is that positive pressure helps open air sacs, reduce collapse, and maintain oxygen and carbon dioxide exchange while the fistula and lung injury are being managed. PubMed PMC
4. Head-up positioning. Keeping the child in a safe semi-upright position can reduce reflux and aspiration into the airway. The purpose is to lower repeated contamination of the lungs. The mechanism is gravity: it makes upward movement of gastric or biliary material into the airway less likely. NCBI NCBI
5. Feeding modification. Small, careful feeds or temporary stopping of oral feeds may be needed in unstable patients. The purpose is to reduce aspiration and improve safety. The mechanism is reducing the amount of material that can move backward and reach the abnormal fistula path. PubMed NCBI
6. Nasogastric or oroenteric decompression. Tube decompression may be used to reduce stomach distension and reflux risk before surgery. The purpose is supportive stabilization. The mechanism is lowering pressure in the upper digestive tract so less content moves toward the fistula. PubMed NCBI
7. Bronchoscopy. Bronchoscopy is one of the most important non-drug treatments because it helps diagnose the opening and can also clear bile or secretions. The purpose is both diagnosis and airway toilet. The mechanism is direct visualization of the airway and removal of obstructing material. PubMed PMC NCBI
8. Fistulography under bronchoscopy guidance. This test is not a cure, but it is a key procedural treatment step because it maps the tract for surgery. The purpose is accurate planning. The mechanism is contrast outlining the abnormal connection so the surgeon knows where to divide and close it. PMC PMC
9. CT or MRI planning. Cross-sectional imaging helps show the fistula route, nearby lung injury, and biliary anatomy. The purpose is safer surgery and better diagnosis. The mechanism is detailed anatomic imaging of the chest and upper abdomen. PMC PMC
10. Cholangiography. Intraoperative or preoperative cholangiography may be used to define biliary drainage. The purpose is to avoid bile duct injury and decide whether extra biliary reconstruction is needed. The mechanism is contrast filling the bile ducts so surgeons can see the exact pathway. PMC PMC
11. Biliary drainage when obstruction exists. If there is bile duct blockage, drainage may be needed. The purpose is to lower bile pressure, infection risk, and leakage through the fistula. The mechanism is decompression of the biliary tree, which can reduce bile flow into the airway. NCBI PMC PMC
12. Chest physiotherapy or airway-clearance therapy. In selected patients with retained secretions, airway-clearance methods may help. The purpose is to move mucus and contaminated secretions out of the lungs. The mechanism is improving mucociliary clearance and cough effectiveness. PMC PMC
13. Nutrition assessment. Malnutrition makes surgery and recovery harder, especially in infants with repeated infection. The purpose is to improve healing and immune function. The mechanism is correcting protein and micronutrient deficits before and after surgery. PMC PMC
14. Oral nutrition supplements when intake is poor. High-calorie and high-protein supplements may be used if the child is undernourished. The purpose is better healing and fewer complications. The mechanism is providing extra protein and energy during recovery. PMC PMC
15. Aspiration precautions. Caregivers and staff should use slow feeding, upright holding, careful burping, and close watching during feeds. The purpose is prevention of recurrent aspiration. The mechanism is reducing the chance that stomach or biliary material reaches the airway. NCBI NCBI
16. Intensive infection monitoring. Recurrent fever, green sputum, worsening oxygen need, or new infiltrates require close review. The purpose is early detection of pneumonia or cholangitis. The mechanism is prompt recognition before severe sepsis or respiratory failure develops. PMC PMC
17. Multidisciplinary planning. The best care usually involves pediatric surgery, thoracic surgery, anesthesia, pulmonology, radiology, and neonatology. The purpose is safer repair in a rare disease. The mechanism is combining expertise for diagnosis, airway control, and biliary reconstruction if needed. PubMed PubMed
18. Thoracoscopic approach when suitable. Minimally invasive thoracoscopy is a procedural non-drug treatment option in selected patients. The purpose is curative resection with less trauma. The mechanism is using small ports and camera guidance to divide and close the fistula tract. PubMed PMC Frontiers
19. Open thoracotomy when anatomy is complex. Some patients still need an open operation. The purpose is secure exposure when the tract is high, thick, inflamed, or close to major structures. The mechanism is direct access that lets the surgeon safely dissect and ligate the fistula. PMC PubMed
20. Long-term follow-up. After repair, the child needs follow-up for cough, recurrent infection, bile leak, feeding problems, or stenosis. The purpose is to confirm cure and catch complications early. The mechanism is ongoing clinical review, and sometimes imaging, after surgery. PubMed PMC
Key drug treatments that may be used supportively
There is no FDA-approved drug that specifically cures congenital respiratory-biliary fistula. The drugs below are supportive options used when the patient has pneumonia, anaerobic infection, severe hospital infection, bronchospasm, fever, reflux, vomiting, or perioperative inflammation. Exact dose depends on age, weight, kidney function, culture results, and specialist judgment. PMC PubMed
1. Ampicillin-sulbactam. This is an important IV antibiotic when aspiration-related chest infection is suspected. It is a beta-lactam plus beta-lactamase inhibitor. FDA labeling says it should be used for proven or strongly suspected bacterial infection. Its purpose is to cover many airway and mixed bacterial infections. The mechanism is killing susceptible bacteria and blocking some beta-lactamase enzymes. Common side effects include diarrhea, rash, and liver test changes. FDA NCBI
2. Piperacillin-tazobactam. This broad IV antibiotic is often used in very sick patients or when biliary and pulmonary infection are both concerns. The FDA label lists a usual adult dose of 3.375 g every 6 hours, usually for 7 to 10 days, but pediatric dosing is specialist-based. Its purpose is broad empiric coverage. The mechanism is bacterial cell-wall inhibition plus beta-lactamase inhibition. Side effects can include diarrhea, low potassium, rash, and kidney issues. FDA
3. Ceftriaxone. Ceftriaxone is a broad-spectrum cephalosporin used for susceptible lower respiratory infections and some biliary infections. Its purpose is infection control when culture or local patterns support it. The mechanism is inhibition of bacterial cell-wall synthesis. Side effects can include diarrhea, rash, biliary sludging, and allergic reaction. FDA FDA
4. Metronidazole. Metronidazole injection is useful when anaerobic bacteria are suspected, especially in aspiration-type infection or mixed biliary infection. The FDA label states that indicated surgical procedures should be performed together with metronidazole, which fits this disease well because drugs alone are not enough. The mechanism is DNA damage in susceptible anaerobic organisms. Side effects include nausea, metallic taste, neuropathy with prolonged use, and liver caution. FDA
5. Clindamycin. Clindamycin is another option for anaerobic coverage in aspiration-related infection when appropriate. Its purpose is treating susceptible anaerobic and gram-positive organisms. The mechanism is blocking bacterial protein synthesis. Important side effects include diarrhea and risk of C. difficile colitis. FDA
6. Vancomycin. Vancomycin may be added if resistant gram-positive infection such as MRSA is suspected in a severe lower respiratory infection. The FDA label includes lower respiratory tract infection due to susceptible isolates. Its purpose is targeted gram-positive coverage, not routine use in every patient. The mechanism is inhibition of bacterial cell-wall synthesis. Side effects include nephrotoxicity, infusion reactions, and ototoxicity risk. FDA
7. Cefepime. Cefepime is a broad cephalosporin used when hospital-acquired or severe gram-negative infection is a concern. Its purpose is strong empiric coverage in selected patients. The mechanism is cell-wall inhibition. Side effects include rash, diarrhea, and neurotoxicity risk in renal impairment. FDA
8. Meropenem. Meropenem is reserved for severe or resistant infection, especially when broad abdominal and airway coverage is needed. FDA labeling includes complicated intra-abdominal infection. Its purpose is rescue broad-spectrum treatment. The mechanism is carbapenem cell-wall inhibition. Side effects include diarrhea, rash, and seizure risk in predisposed patients. FDA FDA
9. Albuterol. Albuterol does not treat the fistula itself, but it may help if the child has wheeze or bronchospasm. The FDA label describes it as a selective beta2 bronchodilator. Its purpose is to open narrowed airways and make breathing easier. The mechanism is relaxation of bronchial smooth muscle. Side effects include fast heartbeat, tremor, and nervousness. FDA
10. Acetaminophen. Acetaminophen is supportive for fever and pain during infection or after surgery. FDA labeling gives pediatric IV dosing of 15 mg/kg every 6 hours for many children, with neonatal dosing lower and less frequent. Its purpose is comfort and fever control. The mechanism is central pain and temperature control. Side effects mainly concern overdose and liver injury. FDA
11. Ondansetron. Ondansetron may be used around surgery or severe vomiting. It does not fix the fistula, but it can reduce vomiting and protect hydration. The mechanism is serotonin 5-HT3 receptor blockade. Side effects may include constipation, headache, and QT prolongation risk. FDA
12. Omeprazole or famotidine. Acid suppression may be useful in selected patients with reflux or irritation, although it does not stop bile from entering the airway through the fistula. The purpose is lowering acid-related injury and reflux symptoms. The mechanism is acid suppression by proton-pump inhibition or H2 blockade. Side effects vary by drug and duration. FDA FDA
Dietary molecular supplements
No supplement has been shown to close this fistula. Supplements are supportive only, mainly for malnutrition, healing, and recovery after infection or surgery. PMC PMC
Protein supplement, arginine-enriched nutrition, vitamin C, zinc, vitamin D, omega-3 fatty acids, iron only if deficient, multivitamin support, calorie-dense oral nutrition products, and pediatric formula support may help some patients who are undernourished or healing after surgery. Their purpose is to improve growth, collagen formation, immune support, and tissue repair. Their mechanism is better substrate supply for healing and recovery, not fistula closure. Any dose should be chosen by a pediatrician or dietitian because infants and children need weight-based plans. PMC PMC PMC PMC
Immunity booster, regenerative, and stem-cell drugs
At present, there are no established FDA-approved immunity booster drugs, regenerative drugs, or stem-cell drugs that are standard treatment for congenital respiratory-biliary fistula. Using those terms for this disease would be misleading. The condition is structural, so the real fix is surgery. Good nutrition and infection control support the immune system, but “immune booster” products should not replace specialist care. PMC PubMed
Surgeries
1. Fistula excision and ligation. This is the main curative surgery. The abnormal tract is identified, divided, and closed to stop bile entering the airway. PubMed PMC
2. Thoracoscopic fistula resection. This minimally invasive operation uses small ports and a camera. It is done to reduce surgical trauma and may allow faster recovery in selected patients. PubMed PMC
3. Open thoracotomy repair. This is done when anatomy is difficult, the patient is unstable, or minimally invasive access is not ideal. It gives wide exposure for safe dissection. PMC
4. Roux-en-Y hepaticojejunostomy. This is needed when normal bile drainage is not possible or the biliary anatomy is abnormal. It creates a new path for bile flow into the intestine. PMC Ann Thorac Surg
5. Lung resection or hepatectomy in selected severe cases. These are not routine, but lobectomy or hepatic resection may be needed if there is severe destroyed lung, complex disease, or major biliary pathology. PMC J Chest Surg
Preventions
This condition cannot usually be prevented before birth because it is congenital. What can be prevented are complications. Important steps are early diagnosis, aspiration precautions, timely surgery, full treatment of bacterial infection, nutritional support, vaccination as advised, smoke-free air, careful follow-up after repair, fast treatment of reflux or vomiting, and urgent review when breathing worsens. These measures reduce recurrent lung damage and severe infection. PubMed PMC NCBI
When to see doctors
See a doctor urgently if a baby or child has green sputum, choking with feeds, repeated pneumonia, fever, fast breathing, chest retractions, blue lips, poor feeding, vomiting, low weight gain, or unusual cough from birth or early infancy. After surgery, seek care quickly for new cough, fever, jaundice, wound redness, persistent vomiting, breathing difficulty, or poor growth. PMC PubMed
What to eat and what to avoid
Good choices are breast milk when safe, specialist-recommended infant formula, high-protein foods in older children, calorie-dense nutrition when underweight, zinc-rich foods, vitamin C foods, iron-rich foods if deficient, vitamin D support when prescribed, small frequent meals, and plenty of fluids if allowed. Foods or patterns to avoid include force feeding, large heavy meals, lying flat right after feeding, foods that worsen reflux in older children, smoke exposure, and unproven supplements sold as cure products. Feeding plans should be individualized by the clinical team. PMC PMC NCBI
FAQs
Is this disease common? No, it is extremely rare. PubMed
Is it present at birth? Yes, it is congenital, meaning present from birth. PMC
Can medicine alone cure it? Usually no; surgery is the main curative treatment. PMC
What is the classic clue? Bile-stained or green sputum is a major clue. PMC
Why does pneumonia keep coming back? Because bile and secretions can keep entering the airway. PubMed
Which test is most useful? Bronchoscopy is one of the most useful tests, usually combined with imaging. PubMed PMC
Can thoracoscopy be used? Yes, in selected cases. PubMed
Do all patients need biliary reconstruction? No, only some do, depending on bile duct anatomy and drainage. PMC
Are antibiotics always needed? No, they are used when infection is present or strongly suspected. FDA
Do supplements cure it? No, they only support healing and nutrition. PMC
Are stem cells a standard treatment? No. PMC
Can this cause poor growth? Yes, repeated infection and feeding problems can affect growth. PubMed
What is the prognosis after proper repair? Many reported patients do well after successful surgical correction. PubMed PMC
Can adults have it? Yes, but most cases present in infancy or childhood. PMC
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: March 12, 2025.
